Marevan

Warfarin, the active ingredient in Marevan, is a Vitamin K antagonist presented as an oral tablet for oral use. It is employed to prevent and treat thromboembolic disorders in patients at risk of clot formation. GNH USA supplies Marevan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Marevan is a Vitamin K antagonist indicated for several thrombotic conditions. - Deep vein thrombosis: prevents clot extension and recurrence in the lower limbs. - Pulmonary embolism: reduces the risk of further embolic events after an initial episode. - Atrial fibrillation (stroke prevention): lowers the incidence of ischemic stroke in patients with non‑valvular atrial fibrillation. - Mechanical heart valves: provides anticoagulation to avoid valve‑related thromboembolism.

Warfarin therapy can be associated with a range of adverse reactions.

Common Side Effects: - Minor gastrointestinal upset, such as nausea or dyspepsia. - Mild bruising or easy bleeding from cuts. - Skin rash or mild itching. - Hair loss (alopecia) in some patients. - Elevated liver enzymes detected on routine labs.

Serious or Rare Side Effects: - Major hemorrhage, including intracranial or gastrointestinal bleeding. - Skin necrosis, often presenting as painful, purplish lesions. - Purple toe syndrome, characterized by painful discoloration of the toes. - Anaphylactic reactions, though extremely uncommon.

Before initiating Marevan, several safety considerations should be addressed. - Baseline testing: obtain INR, complete blood count, and liver function tests. - Monitoring: adjust dose based on regular INR measurements to maintain therapeutic range. - Drug interactions: review all concomitant medications for potential potentiation of anticoagulant effect. - Contraindications: avoid use in patients with active bleeding, severe hepatic impairment, or known hypersensitivity. - Pregnancy: contraindicated due to teratogenic risk (Category X). - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Warfarin has a broad interaction profile that requires careful management.

Major Interactions (Avoid): - Amiodarone: markedly increases INR and bleeding risk. - Azole antifungals (e.g., fluconazole, ketoconazole): potentiate anticoagulant effect. - Certain antibiotics (e.g., trimethoprim‑sulfamethoxazole): elevate INR significantly.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen, naproxen): increase gastrointestinal bleeding risk. - Statins (e.g., simvastatin, atorvastatin): may modestly raise INR. - Vitamin K‑rich foods or supplements: can reduce warfarin efficacy and require dose adjustment.